AstraZeneca
“I’m proud to announce that tomorrow, 58 days into our administration, we will have met our goal,” the president said Thursday.
"We are going beyond the standard practices for safety monitoring," the drug company said amid concerns about its coronavirus vaccine.
The new mid-stage trial will determine whether the coronavirus shot is effective on people between the ages of 6 and 17.
The AstraZeneca vaccine forms the bulk of the stockpile acquired so far by a United Nations-backed effort to deploy coronavirus vaccines globally.
WHAT'S HAPPENING
A preliminary study found the vaccine may be 76% effective if a second shot is given three months later rather than within the shorter window initially proposed.
HuffPost reporters are tracking the latest news on the COVID-19 pandemic.
The country’s drugs regulator gave emergency authorization for the U.K.-based drugmaker AstraZeneca and a locally developed one.
The U.K. became the first country to approve the shot, which has a low cost and is easier to store than other vaccines in use.
More study is needed, however, to determine exactly how effective it is.
The high success rate from one part of the study has come under scrutiny this week. Here's what we know.